Filtros de búsqueda

Lista de obras de

A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation

artículo científico publicado en 2005

Activation of MET by gene amplification or by splice mutations deleting the juxtamembrane domain in primary resected lung cancers

artículo científico publicado en 2009

CRKL amplification is rare as a mechanism for acquired resistance to kinase inhibitors in lung cancers with epidermal growth factor receptor mutation

artículo científico publicado en 2014

Conversion from the "oncogene addiction" to "drug addiction" by intensive inhibition of the EGFR and MET in lung cancer with activating EGFR mutation

artículo científico publicado en 2011

Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinib

artículo científico publicado en 2011

Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32.

artículo científico publicado en 2007

Genotype announcement in a genetic polymorphism study for health checkup examinees at Nagoya University Hospital.

artículo científico publicado en 2004

Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1

artículo científico publicado en 2007

Multiplex PCR with confronting two-pair primers for CYP1A1 Ile462Val, GSTM1, GSTT1, and NQO1 C609T.

artículo científico publicado en 2005

Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers

artículo científico publicado en 2011

Reciprocal and complementary role of MET amplification and EGFR T790M mutation in acquired resistance to kinase inhibitors in lung cancer

artículo científico publicado en 2010

Roles of achaete-scute homologue 1 in DKK1 and E-cadherin repression and neuroendocrine differentiation in lung cancer.

artículo científico publicado en 2008

miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer.

artículo científico publicado en 2011

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda